01 2Gowling WLG (Canada) LLP
02 1Janssen Inc.
01 12368814
02 12612538
03 12961762
01 2MIGLUSTAT
02 1Miglustat
01 2CAPSULE
02 1Capsules
01 11935-09-30
02 12020-04-20
03 12026-05-17
Patent Expiration Date : 2026-05-17
Date Granted : 2015-06-30
Brand Name : OPFOLDA
Patent Number : 2612538
Filing Date : 2006-05-17
Strength per Unit : 65mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-17
Date Granted : 2015-06-30
Patent Expiration Date : 1935-09-30
Date Granted : 2024-03-05
Brand Name : OPFOLDA
Patent Number : 2961762
Filing Date : 2015-09-30
Strength per Unit : 65mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-09-30
Date Granted : 2024-03-05
Patent Expiration Date : 2020-04-20
Date Granted : 2010-09-07
Brand Name : ZAVESCA
Patent Number : 2368814
Filing Date : 2000-04-20
Strength per Unit : 100 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-04-20
Date Granted : 2010-09-07
